FDA Approves New Lung Cancer Treatment and First Next-Gen Companion Diagnostic
Hot on the heels of the FDA’s landmark approval of an anticancer therapeutic for use based on whether a...
Category: Policy
Hot on the heels of the FDA’s landmark approval of an anticancer therapeutic for use based on whether a...
The American Association for Cancer Research (AACR) has appeared in numerous publications lately, showcasing the breadth of our mission...
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...
May is National Cancer Research Month, and for the past 10 years, leaders and members from the American Association...
This time last year there were no immune checkpoint inhibitors approved by the U.S. Food and Drug Administration (FDA)...
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
At the end of last week, the U.S. Food and Drug Administration (FDA) announced the approval of the first...
May is National Cancer Research Month, during which the American Association for Cancer Research partners with advocacy groups, cancer...